Application of New Approach Methodologies to Improve Oral Biopharmaceutic Assessments. [PDF]
García MA +4 more
europepmc +1 more source
Advancing drug development with "Fit-for-Purpose" modeling informed approaches. [PDF]
Sheng J, Zhang T.
europepmc +1 more source
Role of Pharmacogenetics on Tramadol Pharmacokinetics: A Population Pharmacokinetic Model. [PDF]
Soria-Chacartegui P +6 more
europepmc +1 more source
Mastering particle size analysis: lessons, challenges, and future directions from the FDA-CRCG workshop. [PDF]
Xu X +46 more
europepmc +1 more source
Integrating In Vitro BE Checker with In Silico Physiologically Based Biopharmaceutics Modeling to Predict the Pharmacokinetic Profiles of Oral Drug Products. [PDF]
Niino T +6 more
europepmc +1 more source
Emerging perspectives on leveraging physiologically based biopharmaceutics modeling (PBBM) for BCS class III biowaivers: A webinar summary. [PDF]
Fang L +8 more
europepmc +1 more source
Biowaiver monograph for immediate-release solid oral dosage forms: Empagliflozin. [PDF]
Negoya R +13 more
europepmc +1 more source
Challenges for switching central nervous system and psychiatric medication products: A review of the literature. [PDF]
Procyshyn RM +4 more
europepmc +1 more source
Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug Products. [PDF]
Walenga RL +7 more
europepmc +1 more source

